Por el Dr. Juan Carlos Garnica Cuéllar. Especialista en Endocrinología y Biología de la Reproducción. Centro Médico Nacional 20 de Noviembre, ISSSTE. Cédula 7288791.
Estimado Dr (a) le invitamos a ver la siguiente cápsula: “La Prediabetes como una entidad patológica independiente que requiere manejo temprano”
Referencias:
- ADA. Standards of Medical Care in Diabetes. 2015. https://care.diabetesjournals.org/content/suppl/2014/12/23/38.Supplement_1.DC1/January_Supplement_Combined_Final.6-99.pdf
- ISPAD Clinical Practice Consensus Guidelines 2014. https://www.ispad.org/page/httpswwwispadorgpageGuidelines2018Chap4?%26hhsearchterms=%222014%22
- Brannick B, et al. Prediabetes as a Toxic Environment for the Initiation of Microvascular and Macrovascular Complications. Exp Biol Med (Maywood). 2016 Jun;241(12):1323-31.
- Echouffo-Tcheugui JB, et al. Association Between Prediabetes and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Diabet Med. 2016 Dec;33(12):1615-1624.
- Brannick B, et al. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction. Endocrinol Metab Clin North Am. 2018 March; 47(1): 33–50.
- Huang Y, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016 Nov 23;355:i5953.
- Garber AJ, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary. Endocrine Practice: January 2019, Vol. 25, No. 1, pp. 69-100.
Material desarrollado con fines de educación médica continua.
Material exclusivo para profesionales de la salud.
La información aquí presentada es opinión del ponente.
Código interno de aprobación: MX20DI00054
